[18F]T807 PET (TEPTAU)
To examine if there is a different regional pattern of tracer retention across brain regions according to clinical symptoms : temporal for logopenic aphasia and occipital for posterior cortical atrophy.
Patients with AD, patients with Benson disease, and healthy volunteers
17
injection of radioactive tracers, mild discomfort, in clinic visit
PET technician, PET scanner, dyes
University Hospital, Tours
“Tau Brain Imaging in Typical and Atypical Alzheimer's Disease (AD) (TEPTAU).”ClinicalTrials.gov. Accessed October 9, 2019. https://clinicaltrials.gov/ct2/show/NCT03022968?term=biomarker&recrs=abdf&cond=Alzheimer+Disease&draw=6&rank=54